BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16895062)

  • 1. [Infliximab in the treatment of Wegener's granulomatosis: case report].
    Svozílková P; Ríhová E; Brichová M; Diblík P; Kuthan P; Poch T
    Cesk Slov Oftalmol; 2006 Jul; 62(4):280-6. PubMed ID: 16895062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients].
    Lamprecht P; Arbach O; Voswinkel J; Lilienthal T; Nölle B; Heller M; Gause A; Gross WL
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1876-80. PubMed ID: 12235553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
    Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
    Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
    Mukhtyar C; Luqmani R
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv31-6. PubMed ID: 16239383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Wegener's granulomatosis: ocular manifestations, diagnosis and therapy].
    Duncker G; Beigel A; Lehmann H
    Klin Monbl Augenheilkd; 1982 Sep; 181(3):184-7. PubMed ID: 7144012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of necrotizing scleritis in Wegener's granulomatosis after infliximab treatment.
    Kontkanen M; Paimela L; Kaarniranta K
    Acta Ophthalmol; 2010 May; 88(3):e96-7. PubMed ID: 19758399
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular manifestations of Wegener's granulomatosis in north India.
    Bambery P; Gupta A; Sakhuja V; Kaur U; Gangwar DN; Jain IS; Deodhar SD
    Sarcoidosis; 1988 Sep; 5(2):132-5. PubMed ID: 3227186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin.
    Hagen EC; de Keizer RJ; Andrassy K; van Boven WP; Bruijn JA; van Es LA; van der Woude FJ
    Clin Nephrol; 1995 Jun; 43(6):351-9. PubMed ID: 7554518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for refractory Wegener's granulomatosis: a role for rituximab?
    Antoniu SA
    Curr Opin Investig Drugs; 2007 Nov; 8(11):927-32. PubMed ID: 17979026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab efficiency in refractory Wegener's granulomatosis.
    Rozin A
    Rheumatology (Oxford); 2003 Sep; 42(9):1124-5; author reply 1125-6. PubMed ID: 12923277
    [No Abstract]   [Full Text] [Related]  

  • 11. Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-up.
    Odorcic S; Keystone EC; Ma JJ
    Cornea; 2009 Jan; 28(1):89-92. PubMed ID: 19092414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
    Seo P; Specks U; Keogh KA
    J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.
    Kleinert J; Lorenz M; Köstler W; Hörl W; Sunder-Plassmann G; Soleiman A
    Wien Klin Wochenschr; 2004 May; 116(9-10):334-8. PubMed ID: 15237661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab in the treatment of refractory posterior uveitis.
    Joseph A; Raj D; Dua HS; Powell PT; Lanyon PC; Powell RJ
    Ophthalmology; 2003 Jul; 110(7):1449-53. PubMed ID: 12867408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener's granulomatosis.
    Onal S; Kazokoglu H; Koc A; Yavuz S
    Ocul Immunol Inflamm; 2008; 16(5):230-2. PubMed ID: 19065418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
    Knight A; Askling J; Granath F; Sparen P; Ekbom A
    Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infectious aspects of Wegener's granulomatosis].
    Rusterholz D; Schlegel C
    Schweiz Med Wochenschr; 2000; Suppl 125():41S-43S. PubMed ID: 11141937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab as rescue therapy in three cases of paediatric Wegener's granulomatosis.
    Wilkinson NM; Erendzhinova E; Zeft A; Cabral DA
    Rheumatology (Oxford); 2006 Aug; 45(8):1047-8. PubMed ID: 16735453
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).
    Benitez-del-Castillo JM; Martinez-de-la-Casa JM; Pato-Cour E; Méndez-Fernández R; López-Abad C; Matilla M; Garcia-Sanchez J
    Eye (Lond); 2005 Aug; 19(8):841-5. PubMed ID: 15389273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.